Clinical Trial Update: A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 study of the bispecific antibody MCLA-145 in adults with advanced or metastatic malignancies has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma

Drugs mentioned

• MCLA-145

Snippet

Sponsor: Merus B.V. | Conditions: Advanced Cancer, Solid Tumor, Adult | Phase 1 | Status: COMPLETED